Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Satudora Holdings CoTSE:3544 +0.08%55 EV-to-EBITDA is 11.90 as of Aug. 26, 2026, which is 4% above its 10-year median of 11.43. GuruFocus rates TSE:3544 with a GF Score™ of 55/100 and a GF Value™ of 円874.82 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 517 Healthcare Providers & Services companies, Satudora Holdings Co ranks worse than 54.93% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Satudora Holdings Co's enterprise value is 円31,080 Mil.
Satudora Holdings Co's EBITDA for the trailing twelve months (TTM) ended in May. 2026 was 円2,611 Mil. Therefore, Satudora Holdings Co's EV-to-EBITDA for today is 11.90.
The historical rank and industry rank for Satudora Holdings Co's EV-to-EBITDA or its related term are showing as below:
TSE:3544'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.12 Med: 11.43 Max: 18.08
Current: 11.91
During the past 13 years, the highest EV-to-EBITDA of Satudora Holdings Co was 18.08. The lowest was 8.12. And the median was 11.43.
TSE:3544's EV-to-EBITDA is ranked worse than 54.93% of 517
companies
in the Healthcare Providers & Services industry
Industry Median: 10.63
vs TSE:3544: 11.91
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Satudora Holdings Co (TSE:3544) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Satudora Holdings Co's PE Ratio (TTM) for today is calculated as:
Satudora Holdings Co's share price for today is 円1250.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Satudora Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was 円31.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Satudora Holdings Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Satudora Holdings Co EV-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Satudora Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Satudora Holdings Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Satudora Holdings Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Satudora Holdings Co's EV-to-EBITDA falls into.
Satudora Holdings Co's current Enterprise Value is 円31,080 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Satudora Holdings Co's EBITDA for the trailing twelve months (TTM) ended in May. 2026 was 円2,611 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Satudora Holdings Co (TSE:3544) has a EV-to-EBITDA of 11.90 as of Aug. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Satudora Holdings Co. This is near median its historical median of 11.43. Over the past decade, Satudora Holdings Co's EV-to-EBITDA has ranged from 8.12 to 18.08. According to the industry distribution chart, Satudora Holdings Co ranks #284 out of 517 companies in the Healthcare Providers & Services industry, placing it in the top 54.9%.
Is Satudora Holdings Co's EV-to-EBITDA too high?
Satudora Holdings Co's current EV-to-EBITDA of 11.90 is near median its 10-year median of 11.43. Over the past 10 years, this metric has ranged from a low of 8.12 to a high of 18.08. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.63. Satudora Holdings Co's value of 11.90 is 11.9% above this industry median. Based on the distribution chart, Satudora Holdings Co ranks #284 out of 517 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Satudora Holdings Co has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Satudora Holdings Co's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Satudora Holdings Co ranks #284 out of 517 companies for EV-to-EBITDA. This places Satudora Holdings Co in the lower half of its industry. The industry median EV-to-EBITDA is 10.63. Satudora Holdings Co's value of 11.90 is 11.9% above this benchmark. Historically, Satudora Holdings Co's own EV-to-EBITDA has ranged from 8.12 to 18.08 over the past decade. While the company's 10-year median is 11.43 vs. the industry median of 10.63, Satudora Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.63, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Satudora Holdings Co's current EV-to-EBITDA of 11.90 is 11.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Satudora Holdings Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Satudora Holdings Co's current EV-to-EBITDA is 11.90, which is near median its own 10-year median of 11.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satudora Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Satudora Holdings Co (TSE:3544) is currently considered Significantly Overvalued. The stock's GF Value™ is 円874.82, compared to a current price of 円1,250.00 — trading 42.9% above its estimated fair value. The current EV-to-EBITDA is 11.90, which is near median its 10-year median of 11.43 and 11.9% above the Healthcare Providers & Services industry median of 10.63. Satudora Holdings Co's overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Satudora Holdings Co (TSE:3544), the current EV-to-EBITDA is 11.90 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Satudora Holdings Co (TSE:3544) Overvalued in 2026?
Based on GuruFocus' analysis, Satudora Holdings Co stock appears to be overvalued.
The current stock price of 円1,250.00 is trading 42.9% above its estimated GF Value™ of 円874.82.
GuruFocus considers Satudora Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:3544:
EV-to-EBITDA: 11.90 (near median its 10-year median of 11.43)
GF Value™: 円874.82 vs. price of 円1,250.00 (42.9% above fair value)
Industry Position: 11.9% above the Healthcare Providers & Services median (#284 of 517)
No single metric tells the full story. See the TSE:3544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Satudora Holdings Co Ltd operates as a pharmaceutical retailer. The business of the company includes operating drug stores, pharmacies, wholesale and product development, energy business, and other services.
55GF Score
Get the complete analysis for TSE:3544
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3544 has been successfully added to your 
